Ondansetron Tablet, Orally Disintegrating
Product Images NDC 71335-9726

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 71335-9726). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713359726)

Label (Lbl713359726)
Ondansetron Orally Disintegrating Tablets USP 4 mg packaging label showing a bottle containing 30 tablets. The label includes the NDC 71335-9726, warnings about phenylalanine content, storage instructions, and identifies Bryant Ranch Prepack as the repackager and Glenmark Pharmaceuticals Limited as the manufacturer.*
FDA Label Image
FDA Label Image

Structure-base (Structure Base)

Structure-base (Structure Base)
Chemical structure diagram of the active ingredient Ondansetron, showing its molecular framework with carbon, nitrogen, oxygen atoms, and bonds.*
FDA Label Image

Structure-hcl (Structure HCl)

Structure-hcl (Structure HCl)
Chemical structure of Ondansetron hydrochloride dihydrate, showing the fused bicyclic ring system with a methyl-substituted imidazole moiety and associated hydrochloride with two water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.